Across TCGA pan-cancer cohorts, ACTG1P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ACTG1P2’s most consistent transcriptional readouts.

The strongest signal is observed in rectum adenocarcinoma (READ), where ACTG1P2 RNA is repressed in tumor relative to normal tissue. In most cancer types ACTG1P2 is over-expressed in tumor, although a few such as READ and KIRP show the opposite, repressed pattern.

READ and KIRP are the cancer types where ACTG1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ACTG1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
READ	Male	All	−0.086	.003	6	view →
KIRP	All	IV	−0.037	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ACTG1P2 RNA expression & survival · all ACTG1P2 data types